1.00Open2.70Pre Close5 Volume1.18K Open Interest145.00Strike Price500.00Turnover96.20%IV8.45%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry1.00Extrinsic Value100Contract SizeAmericanOptions Type-0.1912Delta0.0174Gamma91.18Leverage Ratio-0.5543Theta-0.0032Rho-17.43Eff Leverage0.0442Vega
Natera Stock Discussion
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
How Natera's New Patent Could Reshape Cancer Detection Technology
Natera Scores Critical Medicare Coverage Win for Lung Cancer Test - What This Means for Patients and Investors
Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection
-Billionaire investor Stanley Druckenmiller told Bloomberg on Wednesday that selling all his Nvidia stock this year was a “big mistake.”
-Nvidia was Druckenmiller's top holding a year ago, but he sold it after the stock tripled in 2023.
-The shares are up another 174% this year, and Druckenmiller has missed much of the continuing rally.
Stanley Druckenmiller is an American billionair...
No comment yet